For some men, it's 'T' time—test or no test

Prescriptions for testosterone therapy have increased significantly during the last 10 years, according to a study in the current issue of JAMA Internal Medicine conducted by researchers at the University of Texas Medical Branch.

About 50 percent of the men in the study who had received testosterone therapy had been diagnosed as having hypogonadism, a condition where a man is unable to produce the normal levels of testosterone.

But the study also found that, among new users of a prescription androgen product, about 25 percent did not have their tested before starting the treatment. In addition, it's unclear what proportion of the 75 percent who were tested had a low level of testosterone.

Dr. Jacques Baillargeon, lead author of the study and an associate professor in and at UTMB, said that he believes this is the first national population-based study of testosterone-prescribing patterns.

See video of Dr. Baillargeon explaining main findings of the study:

This video is not supported by your browser at this time.

Using data from one of the nation's largest commercial health insurance populations, the researchers looked at more than 10 million men age 40 and over. They found that testosterone therapy increased more than threefold, from 0.81 percent in 2001 to 2.91 percent in 2011 in men over 40. By 2011, 2.29 percent of men in their 40s and 3.75 percent of men in their 60s were taking some form of testosterone therapy.

"This trend has been driven, in large part, by direct-to-consumer that have targeted middle-aged men and the expansion of clinics specializing in the treatment of low testosterone—or 'low-T centers,'" said Baillargeon. He noted that the development of and improved delivery mechanisms, particularly topical gels, likely have contributed to the increases. Of the four delivery methods, topical gels showed the highest increase of use.

The study is significant, he said, because there is conflicting data on the short and long-term risks of testosterone therapy.

Related Stories

Buying testosterone supplements online can be risky

May 07, 2013

(HealthDay)—If you're a man suffering from low energy or libido, the drug industry is eager to help. So-called "Low T"—low testosterone—has become a common catch phrase in TV commercials, and sales ...

Drop in testosterone tied to prostate cancer recurrence

Oct 28, 2012

Men whose testosterone drops following radiation therapy for prostate cancer are more likely to experience a change in PSA levels that signals their cancer has returned, according to new research from Fox Chase Cancer Center. ...

Recommended for you

Dendritic cells affect onset and progress of psoriasis

Sep 12, 2014

Different types of dendritic cells in human skin have assorted functions in the early and more advanced stages of psoriasis report researchers in the journal EMBO Molecular Medicine. The scientists suggest that new strate ...

Approach to deadly sepsis infections continues to vary

Sep 12, 2014

Treatment practices for patients hospitalised with the potentially fatal infection known as "sepsis" will continue to vary because of individual differences between hospitals and countries, according to University of Adelaide ...

User comments